Table 2.
Patient clinical characteristics.
| Characteristics | miR-27a-3p | ||
|---|---|---|---|
| Patient number | Mean ± SD | P value | |
| Plasma | <0.001 | ||
| HCC | 90 | 1.66 ± 0.82 | |
| Healthy controls | 75 | ||
| Gender | 0.034 | ||
| Male | 57 | 1.91 ± 0.98 | |
| Female | 33 | 1.33 ± 1.15 | |
| Age | 0.255 | ||
| <55 | 42 | 1.81 ± 1.04 | |
| ≧55 | 48 | 1.85 ± 1.21 | |
| ALT | 0.016 | ||
| Negative | 53 | 1.64 ± 1.14 | |
| Positive | 32 | 1.92 ± 1.03 | |
| AST | 0.001 | ||
| Negative | 39 | 1.39 ± 0.72 | |
| Positive | 51 | 1.40 ± 1.13 | |
| HBV DNA (IU/mL) | 0.113 | ||
| <500 | 58 | 1.40 ± 0.83 | |
| ≧500 | 32 | 0.22 ± 0.71 | |
| AFP (ng/mL) | 0.879 | ||
| <200 | 49 | 1.69 ± 1.05 | |
| ≧200 | 41 | 1.65 ± 1.23 | |
| CEA (μg/L) | 0.677 | ||
| <7.2 | 65 | 0.70 ± 1.12 | |
| ≧7.2 | 25 | 0.43 ± 1.33 | |
| GGT (u/L) | 0.707 | ||
| <55 | 24 | 0.61 ± 1.18 | |
| ≧55 | 66 | 0.72 ± 1.11 | |
| 5′-NT (u/L) | 0.533 | ||
| <10 | 72 | 0.63 ± 1.14 | |
| ≧10 | 18 | 1.00 ± 0.62 | |
| GLU (mmol/L)∗ | 0.047 | ||
| <6.2 | 58 | 0.62 ± 1.14 | |
| ≧6.2 | 32 | 0.81 ± 1.05 | |
AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma glutamyl transferase; GLU: glucose; AFP: alpha fetoprotein.